Related references
Note: Only part of the references are listed.Synthesis and cytotoxicity studies of newly designed benzyl-hydroquinone derivatives
Olivier Tasseau et al.
MEDICINAL CHEMISTRY RESEARCH (2018)
A desirability-based multi objective approach for the virtual screening discovery of broad-spectrum anti-gastric cancer agents
Yunierkis Perez-Castillo et al.
PLOS ONE (2018)
Designing of calixarene based drug carrier for dasatinib, lapatinib and nilotinib using multilevel molecular docking and dynamics simulations
Mohd Athar et al.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY (2018)
KNIME for reproducible cross-domain analysis of life science data
Alexander Fillbrunn et al.
JOURNAL OF BIOTECHNOLOGY (2017)
Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space
Nicholas A. Meanwell
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Predicting human intestinal absorption of diverse chemicals using ensemble learning based QSAR modeling approaches
Nikita Basant et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2016)
The potential of immobilized artificial membrane chromatography to predict human oral absorption
Fotios Tsopelas et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
AutoQSAR: an automated machine learning tool for best-practice quantitative structure-activity relationship modeling
Steven L. Dixon et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Does 'Big Data' exist in medicinal chemistry, and if so, how can it be harnessed?
Igor V. Tetko et al.
FUTURE MEDICINAL CHEMISTRY (2016)
ADME Properties Evaluation in Drug Discovery: Prediction of Caco-2 Cell Permeability Using a Combination of NSGA-II and Boosting
Ning-Ning Wang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Understanding the Roles of the Two QSARs
Toshio Fujita et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System
Yan-Yan Zhang et al.
MOLECULAR PHARMACEUTICS (2016)
Synthesis of new 4-phenylpyrimidine-2(1H)-thiones and their potency to inhibit COX-1 and COX-2
Werner Seebacher et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Multitasking models for quantitative structure-biological effect relationships: current status and future perspectives to speed up drug discovery
Alejandro Speck-Planche et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Template CoMFA Generates Single 3D-QSAR Models that, for Twelve of Twelve Biological Targets, Predict All ChEMBL-Tabulated Affinities
Richard D. Cramer
PLOS ONE (2015)
OpenVirtualToxLab-A platform for generating and exchanging in silico toxicity data
Angelo Vedani et al.
TOXICOLOGY LETTERS (2015)
Global Quantitative Structure-Activity Relationship Models vs Selected Local Models as Predictors of Off-Target Activities for Project Compounds
Robert P. Sheridan
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
QSAR Modeling: Where Have You Been? Where Are You Going To?
Artem Cherkasov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The role of ligand efficiency metrics in drug discovery
Andrew L. Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Critical Evaluation of Human Oral Bioavailability for Pharmaceutical Drugs by Using Various Cheminformatics Approaches
Marlene T. Kim et al.
PHARMACEUTICAL RESEARCH (2014)
Computational Methods in Drug Discovery
Gregory Sliwoski et al.
PHARMACOLOGICAL REVIEWS (2014)
Back to the Future: Can Physical Models of Passive Membrane Permeability Help Reduce Drug Candidate Attrition and Move Us Beyond QSPR?
Robert V. Swift et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2013)
One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade
Bruno O. Villoutreix et al.
DRUG DISCOVERY TODAY (2013)
Considering the impact drug-like properties have on the chance of success
Iskander Yusof et al.
DRUG DISCOVERY TODAY (2013)
Analysis of PPAR-/ Activity by Combining 2-D QSAR and Molecular Simulation
Theodosia Vallianatou et al.
MOLECULAR INFORMATICS (2013)
The Use of Rule-Based and QSPR Approaches in ADME Profiling: A Case Study on Caco-2 Permeability
Hai Pham-The et al.
MOLECULAR INFORMATICS (2013)
Structure and dynamics of molecular networks: A novel paradigm of drug discovery A comprehensive review
Peter Csermely et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Cloud Infrastructures for In Silico Drug Discovery: Economic and Practical Aspects
Daniele D'Agostino et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Polypharmacology: drug discovery for the future
A. Srinivas Reddy et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2013)
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Christopher A. Lipinski et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Softening the Rule of Five-where to draw the line?
Joachim Petit et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
Xuan-Yu Meng et al.
Current Computer-Aided Drug Design (2012)
Multi-Parameter Optimization: Identifying High Quality Compounds with a Balance of Properties
Matthew D. Segall
CURRENT DRUG METABOLISM (2012)
Impact of Lipophilic Efficiency on Compound Quality
Akos Tarcsay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
QSPR in Oral Bioavailability: Specificity or Integrality?
M. A. Cabrera-Perez et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
Desirability-Based Multi-Objective QSAR in Drug Discovery
Maykel Cruz-Monteagudo et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
Comparison of Different Approaches to Define the Applicability Domain of QSAR Models
Faizan Sahigara et al.
MOLECULES (2012)
Quantifying the chemical beauty of drugs
G. Richard Bickerton et al.
NATURE CHEMISTRY (2012)
Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety
Nicholas A. Meanwell
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Cloud Computing Approaches to Accelerate Drug Discovery Value Chain
Vibhav Garg et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2011)
Recent Advances in Ligand-Based Drug Design: Relevance and Utility of the Conformationally Sampled Pharmacophore Approach
Chayan Acharya et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2011)
Prediction of drug intestinal absorption by new linear and non-linear QSPR
Alan Talevi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Predictivity of Simulated ADME AutoQSAR Models over Time
Sarah L. Rodgers et al.
MOLECULAR INFORMATICS (2011)
In Silico Prediction of Caco-2 Cell Permeability by a Classification QSAR Approach
Hai Pham The et al.
MOLECULAR INFORMATICS (2011)
Understanding drug-likeness
Oleg Ursu et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2011)
Multidimensional Drug Design: Simultaneous Analysis of Binding and Relative Efficacy Profiles of N6-substituted-4'-thioadenosines A3 Adenosine Receptor Agonists
Maykel Cruz-Monteagudo et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
Evaluation of Quantitative Structure-Activity Relationship Modeling Strategies: Local and Global Models
Ernst Ahlberg Helgee et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research
Denis Fourches et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Rationalizing fragment based drug discovery for BACE1: insights from FB-QSAR, FB-QSSR, multi objective (MO-QSPR) and MIF studies
Prabu Manoharan et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
Using the Golden Triangle to optimize clearance and oral absorption
Ted W. Johnson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Drug Metabolism for the Perplexed Medicinal Chemist
Bernard Testa
CHEMISTRY & BIODIVERSITY (2009)
Improving Compound Quality throughin vitroandin silicoPhysicochemical Profiling
Han vanâ deâ Waterbeemd
CHEMISTRY & BIODIVERSITY (2009)
Improving Quantitative Structure-Activity Relationships through Multiobjective Optimization
Orazio Nicolotti et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
De Novo Drug Design Using Multiobjective Evolutionary Graphs
Christos A. Nicolaou et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
A constructive approach for discovering new drug leads: Using a kernel methodology for the inverse-QSAR problem
William W. L. Wong et al.
JOURNAL OF CHEMINFORMATICS (2009)
Multi-Objective Feature Selection in QSAR Using a Machine Learning Approach
Axel J. Soto et al.
QSAR & COMBINATORIAL SCIENCE (2009)
Physiochemical drug properties associated with in vivo toxicological outcomes
Jason D. Hughes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Evolving interpretable structure - Activity relationship models. 2. Using multiobjective optimization to derive multiple models
Kristian Birchall et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Desirability-Based Methods of Multiobjective Optimization and Ranking for Global QSAR Studies. Filtering Safe and Potent Drug Candidates from Combinatorial Libraries
Maykel Cruz-Monteagudo et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2008)
QSAR: dead or alive?
Arthur M. Doweyko
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
MultiCASE expert systems and the REACH initiative
Roustem D. Saiakhov et al.
TOXICOLOGY MECHANISMS AND METHODS (2008)
Are the Chemical Structures in Your QSAR Correct?
Douglas Young et al.
QSAR & COMBINATORIAL SCIENCE (2008)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Ligand efficiency indices for effective drug discovery
Cele Abad-Zapatero
EXPERT OPINION ON DRUG DISCOVERY (2007)
QSAR - How good is it in practice? Comparison of descriptor sets on an unbiased cross section of corporate data sets
Peter Gedeck et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
The benefits of the multi-target approach in drug design and discovery
LM Espinoza-Fonseca
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Can we rationally design promiscuous drugs?
AL Hopkins et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
The challenge of predicting drug toxicity in silico
Angelo Vedani et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
Automated QSPR through competitive workflow
J Cartmell et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2005)
Combining protein modeling and 6D-QSAR. Simulating the binding of structurally diverse ligands to the estrogen receptor
A Vedani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The many roles of computation in drug discovery
WL Jorgensen
SCIENCE (2004)
The process of structure-based drug design
AC Anderson
CHEMISTRY & BIOLOGY (2003)
Multiobjective optimization in quantitative structure-activity relationships: Deriving accurate and interpretable QSARs
O Nicolotti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Multiple-conformation and protonation-state representation in 4D-QSAR: The neurokinin-1 receptor system
A Vedani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
